These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Role of monoxygenases in the metabolism of drugs in the human fetus and newborn infant].
    Author: Cresteil T, Leroux JP.
    Journal: Arch Fr Pediatr; 1982; 39(7):463-70. PubMed ID: 6816186.
    Abstract:
    Drug-metabolizing enzyme activities were assayed in human fetuses and neonates and compared with activities in adults. Among these enzymes, only UDP-glucuronosyltransferase exhibited a very low activity, whereas cytochromes P-450, epoxide hydrolase and glutathion S-transferase reached about 50% of adult values as soon as 15-20 weeks of gestational age. Multiple cytochromes P-450 were present in human adults: isoenzymes involved in the metabolism of exogenous substrates such as ethylmorphine, hexobarbital, aniline and diazepam, and endogenous substrates were present and active in the fetus, whereas isoenzyme(s) permitting the hydroxylation of polycyclic aromatic hydrocarbons exhibited a very low activity. A low number of transplacental inductions have been enzymatically studied; only correlations between the pharmacokinetics of a drug in neonates (full-term or premature) and drug intake of the mother during gestation were observed and showed that a treatment with barbiturates significantly increased drug elimination in neonates. Thus, in human fetus and neonate, drug-metabolizing enzymes are present and active, except UDP-glucuronosyltransferase which develops only after birth.
    [Abstract] [Full Text] [Related] [New Search]